Céphalées pharmacorésistantes: nouvelles approches du casse-tête [Drug-resistant headache: is it the end?].
Data(s) |
2012
|
---|---|
Resumo |
Chronic primary headache often cause significant interference with function and quality of life despite acute and preventive medicines. New treatments are emerging for pharmacologically intractable cluster headache and migraine. Occipital nerve stimulation in chronic cluster headache and botulinum toxin in chronic migraine represent the most promising therapies. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_A75670D36480 isbn:1660-9379 (Print) pmid:22675824 |
Idioma(s) |
fr |
Fonte |
Revue Médicale Suisse, vol. 8, no. 339, pp. 937-941 |
Palavras-Chave | #Analgesics/therapeutic use; Cluster Headache/etiology; Cluster Headache/therapy; Drug Resistance/physiology; Headache/drug therapy; Headache Disorders/drug therapy; Humans; Migraine Disorders/etiology; Migraine Disorders/therapy; Neurology/methods; Neurology/trends |
Tipo |
info:eu-repo/semantics/review article |